Related Experiment Video

Updated: Nov 23, 2025

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

16.8K

Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and

Justyna Piekielna-Ciesielska1, Roberto Artali2, Ammar A H Azzam3,4

  • 1Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.

Molecules (Basel, Switzerland)
|December 30, 2020
PubMed

Insights

Two novel cyclopeptides, F-81 and C-33, show biased agonism at µ-opioid receptors (MOP). Structural analysis reveals distinct ligand-receptor interactions, influencing G protein or β-arrestin coupling for potential pain relief with fewer side effects.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Structural Biology

Background:

  • Biased agonism at G protein-coupled receptors (GPCRs), specifically µ-opioid receptors (MOP), is a promising strategy for developing analgesics with reduced side effects.
  • Understanding the molecular basis of this bias is crucial for therapeutic advancement, yet remains a subject of debate.

Purpose of the Study:

  • To investigate the structural basis of G protein-biased (F-81) and β-arrestin 2-biased (C-33) agonism at MOP.
  • To analyze the conformational changes induced by these biased ligands in the MOP complex.

Main Methods:

  • Calcium mobilization assay and bioluminescence resonance energy transfer (BRET) assay to determine initial bias.
  • [35S]GTPγS binding and PathHunter enzyme complementation assays for further bias characterization.
  • NMR spectroscopy, molecular docking, and molecular dynamics simulations for conformational analysis.

Main Results:

  • F-81 and C-33 exhibit distinct affinities and biased signaling profiles at MOP.
  • Conformational analysis predicted alternative ligand-MOP complex formations with specific interactions.
  • These interactions induce differential stabilization of MOP's helix 6, impacting G protein vs. β-arrestin recruitment.

Conclusions:

  • The distinct structural interactions of F-81 and C-33 with MOP underpin their biased signaling.
  • Understanding these structural determinants is key to designing future biased opioid ligands for targeted pain management.
  • This study provides structural insights into GPCR biased agonism, relevant for MOP and other GPCRs.
Keywords:
G-proteinbiased signalingmolecular modelingopioid peptidesβ-arrestin

More Related Videos

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.9K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

9.2K

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.2K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
2.8K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
15.2K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.5K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
9.0K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
129.0K